13.07.2015 Views

rologie i - European Congress of Virology

rologie i - European Congress of Virology

rologie i - European Congress of Virology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

5 th <strong>European</strong> <strong>Congress</strong> <strong>of</strong> <strong>Virology</strong>13h15 – 15h00 LUNCH BREAK (BUFFET) IN THE EXHIBITION AREA Forum 5 & 6, Level -213h30 – 14h45 SYMPOSIUM QIAGEN Room Prestige Gratte-Ciel, Level 2 (p. S81)ACHIEVING CLINICAL AND OPERATIONAL EXCELLENCE THROUGH WORKFLOW OPTIMISATIONChairpersons: Martin SCHUTTEN (Rotterdam, the Netherlands), David BOUTOLLEAU (Paris, FRANCE)13h30 – 14h00 Keynote: Modernizing in house developed molecular assays, the need for automationMartin SCHUTTEN (Rotterdam, the Netherlands)14h00 – 14h20 Detection and quantification <strong>of</strong> CMV DNA in peripheral blood and amniotic fluid in pregnancycomplicated by primary CMV infection, Fausto BALDANTI (Pavia, ITALY)14h20 – 14h40 Improving laboratory efficiency and output: Comparison <strong>of</strong> artus QS-RGQ and establishedin-house workflows Tim CONIBEAR (London, United Kingdom)13h30 – 14h45 SYMPOSIUM SANOFI PASTEUR Room Tête D’Or, Level 1 (p. S82)NEW PARADIGM FOR DENGUE PREVENTIONChairpersons: Nicholas JACKSON (Lyon, FRANCE) - Patrick MAVINGUI (Lyon, FRANCE)13h30 – 13h4513h45 – 14h0014h00 – 14h1514h15-14h3014h30-14h45Characterization <strong>of</strong> the San<strong>of</strong>i Pasteur dengue vaccine candidate: hypotheses andinvestigations to explain results <strong>of</strong> the Phase IIb pro<strong>of</strong>-<strong>of</strong>-concept efficacy trial in RatchaburiBruno GUY (San<strong>of</strong>i Pasteur, Lyon, FRANCE)Role <strong>of</strong> the vector in dengue epidemic dynamicPatrick MAVINGUI (Lyon, France)Arbovirus emergence caused by small genetic changes in the viral genomeAnna-Bella FAILLOUX (Paris, FRANCE)Functional genomic study <strong>of</strong> asymptomatic versus symptomatic dengue viral infectionAnavaj SAKUNTABHAI (Paris, FRANCE)Conclusion, Nicholas JACKSON (Lyon, FRANCE)15h00 – 17h15 WORKSHOP SESSIONSWORKSHOP 7: “CELLULAR FACTORS CONTROLLING VIRAL INFECTION AND ROLE OF HOST GENETICS”Chairpersons: Frank KIRCHHOFF (Ulm, GERMANY) & Aine McKNIGHT (London, UNITED KINGDOM)Room Prestige Gratte-Ciel, Level 2 (p. S83)15h00 – 15h30Keynote: Host cell factors and pathways promoting and restricting hepatitis C virus replicationRalf BARTENSCHLAGER (Heidelberg, GERMANY)15h30 – 15h45 Hepatitis C virus infection modulates the central carbon metabolism <strong>of</strong> the cell,Olivier DIAZ (Lyon, France)15h45 – 16h00 Coxsackievirus Hijacks Host miRNA 126 to Mediate Cross talk <strong>of</strong> ERK and Wnt/beta cateninSignal Pathways for Its Replication, Decheng YANG (Vancouver, CANADA)16h00 – 16h15 Human respiratory syncytial virus infection is modulated by Streptococcus pneumoniaDuy Tien NGUYEN (Rotterdam, THE NETHERLANDS)16h15 – 16h30 Gene loss and adaptation to hominoids underlie the ancient origin <strong>of</strong> HIV 1,Lucie ETIENNE (Seattle, USA)16h30 – 16h45 A novel mechanism <strong>of</strong> human cytomegalovirus evasion from restriction factore IFI16,Valentina DELL’OSTE (Turin, ITALY)16h45 – 17h00 Use <strong>of</strong> exome sequencing and RNAi to understand the influence <strong>of</strong> host factors on theoutcome <strong>of</strong> influenza Infection, Rachael WASH (Cambridge, UNITED KINGDOM)17h00 – 17h15 Characterization <strong>of</strong> one novel interferon stimulated gene participating in the type I interferonblock to HIV1 infection, Caroline GOUJON (London, UNITED KINGDOM)S28Vi<strong>rologie</strong>, Vol. 17, supplément 2, septembre 2013

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!